Acyclovir is NOT Indicated for Canker Sores (Aphthous Ulcers)
Acyclovir should not be used for the treatment of aphthous ulcers (canker sores), as these are non-viral lesions that do not respond to antiviral therapy. This is a critical distinction that must be made in clinical practice, as canker sores are fundamentally different from herpes simplex virus (HSV) infections.
Key Distinction: Aphthous Ulcers vs. Herpes Simplex
Etiology and Pathophysiology
- Aphthous ulcers (canker sores) are immunopathic lesions, not viral infections 1
- These lesions occur on non-keratinized oral mucosa (inside cheeks, lips, soft palate) and are recurrent inflammatory conditions 1
- Herpes simplex lesions, by contrast, are viral infections that typically affect keratinized tissue (lips, hard palate, gingiva) and respond to acyclovir 2, 3
Evidence Against Acyclovir for Aphthous Ulcers
- A controlled trial specifically demonstrated that oral acyclovir has no effect on preventing aphthous stomatitis 4
- In a one-year double-blind study of 44 patients, those receiving daily oral acyclovir showed no significant difference in frequency, duration, or recurrence of canker sores compared to those receiving intermittent treatment 4
- Another randomized, double-blind trial in Behçet's syndrome (which includes aphthous-type ulcers) confirmed that acyclovir failed to alleviate orogenital ulceration 5
FDA-Approved Indications for Acyclovir
The FDA label clearly specifies acyclovir's approved uses, which do NOT include aphthous ulcers 6:
- Herpes zoster (shingles)
- Genital herpes (initial and recurrent episodes)
- Chickenpox (varicella)
Appropriate Treatment for Aphthous Ulcers
The mainstay of aphthous ulcer management is topical or systemic corticosteroids, not antivirals 1:
- Topical corticosteroids (triamcinolone, fluocinonide, clobetasol) consistently reduce pain and shorten healing time 7, 1
- Hyaluronic acid and low-level laser therapy show favorable short-term efficacy 7
- Systemic agents (colchicine, thalidomide) are reserved for severe or refractory cases 7
Clinical Pitfall to Avoid
The most common error is misdiagnosing herpes labialis (cold sores) as aphthous ulcers or vice versa:
- Herpes labialis appears on the lips and keratinized oral surfaces, begins as vesicles that rupture, and responds to acyclovir 8, 1
- Aphthous ulcers appear on non-keratinized mucosa (inside mouth), present as ulcers from onset (not vesicles), and do NOT respond to acyclovir 4, 1
- If uncertain about diagnosis, consider that acyclovir prophylaxis in immunocompromised patients reduced intraoral ulcers excluding the soft palate (suggesting HSV etiology), but did NOT reduce soft palate ulcers (suggesting non-herpetic etiology) 9
When Acyclovir IS Appropriate for Oral Lesions
Acyclovir is indicated for oral HSV infections, specifically 3:
- Moderate to severe herpetic gingivostomatitis: Acyclovir 5-10 mg/kg IV three times daily, then switch to oral when lesions regress 3
- Mild herpetic gingivostomatitis: Acyclovir 20 mg/kg (max 400 mg) orally three times daily for 5-10 days 3
- Herpes labialis (cold sores): Short-course, high-dose oral antiviral therapy decreases outbreak duration and pain by approximately 1 day 8